Diagnostic Medical Systems SA
PAR:ALDMS
Balance Sheet
Balance Sheet Decomposition
Diagnostic Medical Systems SA
Diagnostic Medical Systems SA
Balance Sheet
Diagnostic Medical Systems SA
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
8
|
4
|
1
|
1
|
2
|
4
|
4
|
5
|
5
|
|
| Cash |
0
|
0
|
1
|
1
|
2
|
4
|
4
|
5
|
5
|
|
| Cash Equivalents |
8
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Receivables |
10
|
9
|
10
|
11
|
9
|
10
|
10
|
9
|
9
|
|
| Accounts Receivables |
10
|
9
|
8
|
8
|
7
|
7
|
6
|
7
|
7
|
|
| Other Receivables |
0
|
0
|
3
|
3
|
2
|
4
|
5
|
2
|
1
|
|
| Inventory |
12
|
9
|
10
|
10
|
13
|
12
|
13
|
16
|
14
|
|
| Other Current Assets |
5
|
4
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Current Assets |
35
|
27
|
23
|
24
|
24
|
28
|
29
|
32
|
30
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
7
|
6
|
5
|
5
|
5
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
7
|
6
|
5
|
5
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
3
|
8
|
3
|
3
|
3
|
4
|
4
|
|
| Intangible Assets |
7
|
7
|
9
|
11
|
10
|
9
|
7
|
9
|
11
|
|
| Goodwill |
6
|
4
|
4
|
4
|
4
|
4
|
1
|
5
|
8
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
4
|
2
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
2
|
10
|
0
|
0
|
|
| Other Assets |
6
|
4
|
4
|
4
|
4
|
4
|
1
|
5
|
8
|
|
| Total Assets |
50
N/A
|
40
-20%
|
37
-8%
|
40
+9%
|
46
+14%
|
53
+16%
|
54
+2%
|
51
-5%
|
54
+5%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
10
|
7
|
9
|
11
|
8
|
10
|
11
|
10
|
11
|
|
| Accrued Liabilities |
0
|
0
|
2
|
3
|
5
|
4
|
3
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
4
|
1
|
3
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
3
|
3
|
3
|
3
|
3
|
5
|
7
|
9
|
|
| Other Current Liabilities |
3
|
3
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Total Current Liabilities |
17
|
13
|
15
|
22
|
18
|
21
|
21
|
22
|
23
|
|
| Long-Term Debt |
3
|
3
|
3
|
3
|
10
|
10
|
10
|
13
|
12
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
4
|
0
|
0
|
0
|
0
|
2
|
3
|
1
|
1
|
|
| Other Liabilities |
2
|
1
|
1
|
1
|
0
|
2
|
5
|
2
|
5
|
|
| Total Liabilities |
25
N/A
|
17
-34%
|
19
+13%
|
26
+36%
|
29
+12%
|
34
+19%
|
38
+11%
|
39
+1%
|
41
+6%
|
|
| Equity | ||||||||||
| Common Stock |
25
|
26
|
22
|
19
|
19
|
19
|
19
|
21
|
25
|
|
| Retained Earnings |
2
|
4
|
5
|
6
|
3
|
2
|
5
|
11
|
14
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
25
N/A
|
23
-5%
|
18
-23%
|
15
-19%
|
17
+16%
|
19
+10%
|
16
-16%
|
12
-21%
|
13
+4%
|
|
| Total Liabilities & Equity |
50
N/A
|
40
-20%
|
37
-8%
|
40
+9%
|
46
+14%
|
53
+16%
|
54
+2%
|
51
-5%
|
54
+5%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
16
|
16
|
16
|
16
|
16
|
16
|
16
|
18
|
21
|
|